Charles Reay Mackay

Founder at G2 Therapies Pty Ltd.

Health Technology

Commercial Services

Profile

Charles Reay Mackay is the founder and director of G2 Therapies Pty Ltd, which was founded in 2002.
He was also the Head of Immunology & Inflammation Programme at The Garvan Institute of Medical Research.

Charles Reay Mackay active positions

Companies	Position	Start
G2 Therapies Pty Ltd. G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia.	Founder	29/10/2010

All active positions of Charles Reay Mackay

Former positions of Charles Reay Mackay

Companies	Position	End
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Corporate Officer/Principal	-

See the detail of Charles Reay Mackay's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Reay Mackay's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
G2 Therapies Pty Ltd. G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia.	Health Technology
The Garvan Institute of Medical Research The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia.	Commercial Services